Balyasny Asset Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,894
Closed -$54.8K 2645
2023
Q1
$54.8K Buy
1,894
+1,073
+131% +$28.6K ﹤0.01% 2381
2022
Q4
$22.8K Buy
+821
New +$31.2K ﹤0.01% 2468

Other funds holding OPTN

Balyasny Asset Management's OPTN Position: Q2 2023 in Review

Balyasny Asset Management sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 1,894 shares — an estimated $54.8K sold.

Balyasny Asset Management first reported a position in OPTN in Q4 2022 and held it in 2 quarters. The position peaked at $54.8K in Q1 2023. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

  • Balyasny Asset Management reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 1,894 OptiNose shares in Q2 2023, an estimated $54.8K.
  • Balyasny Asset Management first reported a position in OptiNose in Q4 2022 and held it in 2 quarters.
  • Balyasny Asset Management's OptiNose position peaked at $54.8K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.